Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA minor groove alkylating agents.

W A Denny1

  • 1Auckland Cancer Society Research Centre, School of Biomedical and Health Sciences, The University of Auckland, Auckland, Private Bag 92109, New Zealand.

Current Medicinal Chemistry
|April 3, 2001
PubMed
Summary

Researchers reviewed anticancer agents that target DNA minor groove alkylation. Attaching DNA alkylators to carrier molecules alters their DNA binding selectivity, enhancing targeted cancer therapy potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.

The Journal of antimicrobial chemotherapy·2016
Same author

A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells.

Molecular bioSystems·2016
Same author

The preclinical pharmacokinetic disposition of a series of perforin-inhibitors as potential immunosuppressive agents.

European journal of drug metabolism and pharmacokinetics·2014
Same author

An indoline-derived compound that markedly reduces mouse body weight.

International journal of obesity (2005)·2012
Same author

Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver.

British journal of pharmacology·2010
Same author

ATP site-directed kinase inhibitors.

IDrugs : the investigational drugs journal·2008

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • DNA minor groove alkylating agents are a significant class of anticancer drugs.
  • Understanding their DNA binding selectivity is crucial for developing targeted therapies.
  • Previous research focused on major groove alkylation, but minor groove targeting offers new therapeutic avenues.

Purpose of the Study:

  • To review recent advancements in DNA minor groove alkylating anticancer agents.
  • To explore how carrier molecules influence the DNA binding and selectivity of these agents.
  • To discuss the alkylation patterns of different classes of minor groove binders.

Main Methods:

  • Review of existing scientific literature on DNA minor groove alkylating agents.
  • Analysis of studies detailing the use of carrier molecules to modify alkylator selectivity.
  • Comparison of alkylation patterns for nitrogen mustards, pyrrolizidine alkylators, pyrrolobenzodiazepines, and cyclopropaindolones.

Main Results:

  • Carrier molecules significantly alter the DNA regio- and sequence-selectivity of nitrogen mustards, shifting binding from guanine N7 sites to adenine N3 sites in the minor groove.
  • Carrier molecules have minimal impact on the alkylation patterns of pyrrolizidine alkylators, which continue to target the 2-amino group of guanine.
  • Recent work on pyrrolobenzodiazepine and cyclopropaindolone natural products as minor groove binders is also highlighted.

Conclusions:

  • The strategic attachment of carrier molecules to DNA alkylators can reprogram their DNA binding selectivity, offering a powerful strategy for designing novel anticancer agents.
  • While nitrogen mustards show altered selectivity with carriers, other agents like pyrrolizidine alkylators exhibit consistent alkylation patterns.
  • Further research into minor groove binders holds promise for developing more effective and selective cancer therapies.

Related Experiment Videos